Chimeric ligand/immunoglobulin molecules and their uses
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 20, 1994
Issued Date -
N/A
app pub date -
Jun 10, 1993
filing date -
Jun 1, 1990
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Chimeric molecules having a ligand component linked to an immunoglobulin constant region component are provided for various diagnostic, therapeutic and other uses. These immunoligands can exhibit the high degree of specificity associated with the ligand, yet retain various effector functions characteristic of immunoglobulin heavy chains.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully